Jingjing Sun, PhD
Dr. Sun is an Assistant Professor in the Department of Pharmaceutical Sciences. Before joining UNMC, she served as a Research Assistant Professor at University of Pittsburgh. Dr. Sun's research mainly focuses on the utilization of interdisciplinary approaches including chemistry, bioinformatics, cancer biology and immunology to develop new nanoformulations for the treatment of cancer and other diseases.
Dr. Sun's research interests include: design and development of nanocarriers for efficient delivery of small molecular agents and/or therapeutic genes (e.g. siRNA, plasmid, miRNA) into tumors for cancer therapy, the development of new strategies to overcome the major barriers in clinical translation of nanomedicines and investigation of the underlying mechanism behind the nanomedicine-based cancer immunotherapy and targeted therapy.
- Co-delivery of small molecule drugs for cancer combination therapy (e.g. chemotherapy, immunotherapy and targeted therapy).
- Co-delivery of nucleic acid (siRNA, miRNA and mRNA) and small molecule drugs for cancer prevention or combination therapy.
- Investigate the interaction between nanocarrier, therapeutic agents and biological system.
College of Pharmacy
Department of Pharmaceutical Sciences
University of Nebraska Medical Center
986125 Nebraska Medical Center
Omaha, NE 68198-5965